Literature DB >> 32476876

Non-tuberculous mycobacterial pulmonary disease: an Italian National survey.

Bruno Del Prato1, Alfonso Maria Altieri2, Biagio Carlucci3, Pier Anselmo Mori4, Roberto Parrella5, Anna Stainer6, Federica De Giacomi6, Alberto Pesci6, Paola Faverio6.   

Abstract

The incidence of non-tuberculous mycobacteria (NTM) infection is increasing in Europe. However, a picture of Italian epidemiology and clinical practice is missing. We performed a national Italian survey involving 42 respiratory medicine departments. The NTM species more frequently isolated were Mycobacterium avium complex, followed by M. xenopi and M. kansasii. Patients with NTM were more frequently female (57%), and over 60 years of age, with bronchiectasis and COPD as main comorbidities. Bronchoscopic samples were widely used in the diagnostic phase. Of all patients with NTM, 73% met the criteria for NTM pulmonary disease. Despite strong adherence to the guidelines, physicians found significant difficulties related to pharmacological adverse events, patients' compliance and poor outcomes. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 21-25). Copyright:
© 2018.

Entities:  

Keywords:  epidemiology; non-tuberculous mycobacterial pulmonary disease; survey

Year:  2018        PMID: 32476876      PMCID: PMC7170062          DOI: 10.36141/svdld.v35i1.6979

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  7 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Steven McNulty; Julie V Philley; Jessica Killingley; Rebecca W Wilson; Deanna S York; Sara Shepherd; David E Griffith
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

Review 3.  Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.

Authors:  Lars-Olof Larsson; Eva Polverino; Wouter Hoefsloot; Luigi R Codecasa; Roland Diel; Stephen G Jenkins; Michael R Loebinger
Journal:  Expert Rev Respir Med       Date:  2017-10-10       Impact factor: 3.772

Review 4.  Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis.

Authors:  H-B Xu; R-H Jiang; L Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-25       Impact factor: 3.267

5.  Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.

Authors:  J Mencarini; C Cresci; M T Simonetti; C Truppa; G Camiciottoli; M L Frilli; P G Rogasi; S Veloci; M Pistolesi; G M Rossolini; A Bartoloni; F Bartalesi
Journal:  Epidemiol Infect       Date:  2016-11-02       Impact factor: 4.434

6.  Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.

Authors:  Paola Faverio; Anna Stainer; Giulia Bonaiti; Stefano C Zucchetti; Edoardo Simonetta; Giuseppe Lapadula; Almerico Marruchella; Andrea Gori; Francesco Blasi; Luigi Codecasa; Alberto Pesci; James D Chalmers; Michael R Loebinger; Stefano Aliberti
Journal:  Int J Mol Sci       Date:  2016-11-16       Impact factor: 5.923

7.  Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014.

Authors:  Laura Rindi; Carlo Garzelli
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.